Cell Culture Market Snapshot , Market Size Estimation , Key Industry Insights

By -

The cell culture market is projected to reach USD 18,630.7 Million by 2020 from USD 11,310.9 Million in 2015

(EMAILWIRE.COM, January 31, 2017 ) The increasing incidence of chronic diseases, growth in the number of regulatory approvals for cell culture-based vaccines, rising demand for mAbs, funding for cell-based research, growing use of single-use technologies, and technological advancements in cell culture products are key factors driving the market growth. However, factors such as high cost of research in cell biology and lack of infrastructure for cell-based research may hinder the market growth.

Browse 232 market data Tables and 57 Figures spread through 264 Pages and in-depth TOC on "Cell Culture Market- Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

Based on products, the cell culture market is segmented into instruments and consumables. The consumables segment is expected to account for the largest share in 2015. This segment is also slated to witness the highest CAGR during the forecast period owing to the repeated purchase of consumables compared to instruments.

Based on applications, the cell culture market is segmented into biopharmaceutical/therapeutics, stem cell technologies, drug screening & development, tissue engineering & regenerative medicine, cancer research, and other applications. The biopharmaceutical/therapeutics segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing benefits of cell culture-based vaccines coupled with increasing regulatory approvals. In addition to this, the increasing risk of pandemics and communicable diseases is one of the key factors driving the growth of this market.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=559

Based on end users, the market is segmented into pharmaceutical & biotechnology companies and research institutes. The market for pharmaceutical and biotechnology companies is expected to witness the highest CAGR due to the increasing number of regulatory approvals for cell culture-based vaccines and the presence of a large number of pharmaceutical companies in the cell culture market.

The global market is dominated by North America, followed by Europe. The market in Asia is expected to witness the highest CAGR during the forecast period. Factors such as favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing cost, and growing focus of global market players are expected to fuel the growth in emerging Asian economies.

Key players in this market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (U.K.), Lonza Group AG (Switzerland), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), Eppendorf AG (Germany), Hi-Media Laboratories (India), Sartorius AG (Germany), and Promocell GmbH (Germany).

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more